SCHEMBL2986753

SCHEMBL2986753

c1cncc(CC2=NCCC2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.56
CYP1A2 P05177 2/20 0.49
ALDH1A1 P00352 1/20 0.49
THRB P10828 1/20 0.49
CYP2C19 P33261 1/20 0.49
CHRNB2 P17787 3/20 0.45
CHRNA4 P43681 3/20 0.45
HRH4 Q9H3N8 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CYP2A6 P11509 1/20 0.43
CYP2D6 P10635 1/20 0.43
CHRNA7 P36544 2/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL697719 0.80 TAAR1 (0.44) HSD17B10CYP1A2ALDH1A1CHRNB4CHRNA3
SCHEMBL727185 0.74 CYP1A2 (0.62) CYP1A2CHRNB2CHRNA4HRH4HRH3
SCHEMBL28951692 0.74 CYP1A2 (0.52) CYP1A2CHRNB2CHRNA4HRH4HRH3
SCHEMBL7115844 0.73 TAAR1 (0.56) HSD17B10CYP1A2CHRNB2CHRNA4HRH4
SCHEMBL20746327 0.71 CHRNB2 (0.43) HSD17B10CYP1A2ALDH1A1THRBCHRNB2
SCHEMBL1429748 0.69 ALOX15 (0.46) ALDH1A1CYP2C19CHRNB4CHRNA3CYP2D6
SCHEMBL7004570 0.69 TAAR1 (0.69) CYP1A2CYP2D6
SCHEMBL15293883 0.69 CHRNB2 (0.45) ALDH1A1CHRNB2CHRNA4HRH3CYP19A1
SCHEMBL14257669 0.69 CYP1A2 (0.56) CYP1A2CHRNB2CHRNA4HRH4HRH3
SCHEMBL29995759 0.69 CYP11B1 (0.65) CYP1A2CYP2C19HRH4HRH3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324064-A1 NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE (US) 2010-12-23 US disclosed
US-7786147-B2 Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders Medical College of Georgia Research Institute. (US) 2010-08-31 US disclosed
US-20050227993-A1 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324064-A1 NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS CDR2, CHAT, CHRNA2 HSD17B10 3574/4885CYP1A2 4716/4885ALDH1A1 2925/4885
US-20050227993-A1 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders CDR2, CHAT, CHRNA2 HSD17B10 3574/4885CYP1A2 4716/4885ALDH1A1 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.